Eiji Kikuchi

Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.

S. Boorjian, J. Raman, H. Djaladat, 2024, European urology oncology.

Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer".

N. Hayakawa, Eiji Kikuchi, 2024, International journal of urology : official journal of the Japanese Urological Association.

Editorial Comment to “Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non‐muscle‐invasive bladder cancer: A retrospective multicenter study”

N. Hayakawa, Eiji Kikuchi, 2023, International journal of urology : official journal of the Japanese Urological Association.

Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories

R. Kanesvaran, L. Lee, Chi-Fai Ng, 2023, International journal of urology : official journal of the Japanese Urological Association.

Controversies in terminology associated with management of BCG‐unresponsive NMIBC in Asia‐Pacific

R. Kanesvaran, L. Lee, Chi-Fai Ng, 2023, International journal of urology : official journal of the Japanese Urological Association.

The first detailed annual record on the National Clinical Database Urology Division in Japan: A report on five surgical procedures.

R. Mizuno, N. Hayakawa, Shuichi Morizane, 2024, International journal of urology : official journal of the Japanese Urological Association.

Editorial Comment on “Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification”

N. Hayakawa, Eiji Kikuchi, 2024, International journal of urology : official journal of the Japanese Urological Association.

J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan.

C. Kitagawa, N. Nishiyama, K. Fujimoto, 2024, International journal of urology : official journal of the Japanese Urological Association.

Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)

E. Kikuchi, N. Hayakawa, Eiji Kikuchi, 2022, International journal of urology : official journal of the Japanese Urological Association.

Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association

H. Kume, C. Ohyama, N. Masumori, 2023, International journal of urology : official journal of the Japanese Urological Association.